Literature DB >> 17483348

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling.

Bo Huang1, Jie Zhao, Shiqian Shen, Hongxing Li, Kai-Li He, Guan-Xin Shen, Lloyd Mayer, Jay Unkeless, Dong Li, Ye Yuan, Gui-Mei Zhang, Huabao Xiong, Zuo-Hua Feng.   

Abstract

The contribution of bacterial infection to tumorigenesis is usually ascribed to infection-associated inflammation. An alternate view is that direct interaction of bacteria with tumor cells promotes tumor progression. Here, we show that the microenvironment of large tumors favors bacterial survival, which in turn directly accelerates tumor growth by activating tumor cell Toll-like receptors (TLR). Listeria monocytogenes (Lm) survives in the microenvironment of large but not small tumors, resulting in the promotion of tumor growth. Lm did not affect the percentage of regulatory T cells or myeloid suppressor cells in the tumor. Through TLR2 signaling, Lm activated mitogen-activated protein kinases and nuclear factor-kappaB in tumor cells, resulting in the increased production of nitric oxide and interleukin-6 and increased proliferation of tumor cells. All of these effects were abrogated by silencing expression of TLR2, but not TLR4. The interaction of Helicobacter pylori with tumor cells from gastric carcinoma patients resulted in similar effects. These findings provide a new insight into infection-associated tumorigenesis and illustrate the importance of antibiotic therapy to treat tumors with bacterial infiltration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483348     DOI: 10.1158/0008-5472.CAN-06-4067

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  70 in total

1.  Impacts of K562 cells towards activities of Toll-like receptor pathway of human mesenchymal stem cell-bone marrow.

Authors:  Zheng Xu; Jianmin Luo; Lin Yang; Xingzhe Wang; Yuxia Pan; Yintao Shang; Jingci Yang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

Review 3.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

4.  Squamous carcinoma cells influence monocyte phenotype and suppress lipopolysaccharide-induced TNF-alpha in monocytes.

Authors:  Aroonwan Lam-ubol; Dustin Hopkin; Elena M Letuchy; Zoya B Kurago
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

5.  Microparticles released by Listeria monocytogenes-infected macrophages are required for dendritic cell-elicited protective immunity.

Authors:  Yi Zhang; Ruihua Zhang; Huafeng Zhang; Jing Liu; Zhuoshun Yang; Pingwei Xu; Wenqian Cai; Geming Lu; Miao Cui; Reto A Schwendener; Huang-Zhong Shi; Huabao Xiong; Bo Huang
Journal:  Cell Mol Immunol       Date:  2012-10-08       Impact factor: 11.530

6.  Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.

Authors:  Paulo Cesar Maciag; Matthew M Seavey; Zhen-Kun Pan; Soldano Ferrone; Yvonne Paterson
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

7.  Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cells.

Authors:  Wenjie Xie; Yafang Huang; Wenling Xie; Aimin Guo; Wei Wu
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

8.  Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model.

Authors:  Zhuoshun Yang; Biao Zhang; Dapeng Li; Meng Lv; Chunmei Huang; Guan-Xin Shen; Bo Huang
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

Review 9.  Toll-like receptors, tissue injury, and tumourigenesis.

Authors:  Savvas Ioannou; Michael Voulgarelis
Journal:  Mediators Inflamm       Date:  2010-09-14       Impact factor: 4.711

10.  Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Authors:  Huan Yang; Huiqin Zhou; Ping Feng; Xiaoni Zhou; Huiyan Wen; Xiaofang Xie; Haiying Shen; Xueming Zhu
Journal:  J Exp Clin Cancer Res       Date:  2010-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.